Skip to main content
Fig. 5 | Journal of Neuroinflammation

Fig. 5

From: Peroxisome proliferator-activated receptor-gamma: potential molecular therapeutic target for HIV-1-associated brain inflammation

Fig. 5

Effect of HIV-1ADA gp120 on the protein and mRNA expression of PPARĪ³ in vitro and in vivo. Primary cultures of rat astrocytes were exposed to g120 (5Ā nM) for 6Ā h, and PPARĪ³ mRNA levels were measured using qPCR (a). Primary cultures of mixed rat astrocytes and microglia were exposed to g120 (5Ā nM) for 3Ā h, and PPARĪ³ mRNA levels were measured using qPCR (b). Adult Wistar rats were administered, bilateral ICV, 4Ā Ī¼g/ventricle of gp120; hippocampus was isolated 6ā€“72Ā h post ICV, and PPARĪ³ mRNA levels were measured using qPCR (c), and protein expression of PPARĪ³ was analyzed through immunoblotting (d). Cyclophillin was used as the housekeeping gene for qPCR. For immunoblotting, hippocampus tissue protein lysates (50Ā Ī¼g) were resolved on a 10% SDS-polyacrylamide gel and transferred to a PVDF membrane. HepG2 (50Ā Ī¼g) were used as positive control for PPARĪ³ protein. PPARĪ³ was detected using a rabbit polyclonal PPARĪ³ antibody (1:1000 dilution). pt?>Actin was detected using a mouse monoclonal antibody (1:5000, dilution). Data generated from densitometric analysis is presented as a ratio of PPARĪ³ expression normalized to actin (loading control). Results are expressed as meanĀ Ā±Ā SEM relative to DMSO (control, in vitro) or saline (control, in vivo) of at least 3 separate experiments in vitro and nĀ =Ā 6ā€“11 animals/group in vivo. Asterisks represent data point significantly different from DMSO or saline (control) (****pĀ <Ā 0.0001, *pĀ <Ā 0.05)

Back to article page